Elsevier Announces the Launch of a New Journal: Obesity Medicine
Amsterdam, September 22, 2015
Obesity Medicine will provide the latest information in clinical research on obesity. It will serve clinical scientists in all disciplines, medical practitioners, health-care providers as well as social scientists and the public interested in scientific information on all aspects of obesity.
The journal welcomes papers on original observations and research on the causes of obesity, prevention and treatment, comorbidities and social and psychological as well as societal and financial impacts. In addition, state-of-the-art reviews and an occasional prismatic case will be published.
Professor Wieland Kiess MD (University of Leipzig), Editor-in-Chief of Obesity Medicine, said, “Obesity Medicine aims to publish research combining translational and interdisciplinary work. A team of international scientists have been selected as Editorial Board and Associate Editors and will support me in my work as editor. We very much look forward to working with our authors and readers in developing what we hope will become a key reference for obesity research.”
Andrew Miller PhD, Executive Publisher at Elsevier, said, “We are proud to launch Obesity Medicine given the challenging and highly significant nature of the disease internationally. We look forward to developing it in liaison with Professor Kiess and other leading researchers in the community to help advance research, education and treatment in obesity.”
The journal will appear four times a year online and will be rolled out in Elsevier’s brand new electronic submission and review system EVISE®. The journal will also follow the Article Based Publishing scheme, allowing papers to appear fully citable online just shortly after acceptance.
For more information or to submit an article, go to www.obesitymedicinejournal.com
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com